It is a pharma private limited company based in Sahibabad, Uttar Pradesh, India, established in 2011.
2011 | Sahibabad, Uttar Pradesh, India | ActiveMaxlive Pharmaceuticals Private Limited, a active private limited company, was established on 29 December 2011 in Sahibabad, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24233UP2011PTC048133. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Its leadership includes Manoj Kumar (Director), Ankur Vashishtha (Director). Past directors included Amit Singh, Ankur Vashishtha. It holds ₹12.59 Cr open charges and ₹8.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. Ii-7/6 Ground Floor, Block-7, Sector-2, Rajendra Nagar, Sahibabad, Uttar Pradesh, 201005.
U24233UP2011PTC048133
048133
29 December 2011
₹3.00 M
₹3.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Maxlive Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Kumar | Director | 29 Dec 2011 | Current |
| Ankur Vashishtha | Director | 03 Nov 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Nov 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maxlive Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.26% decrease. The company also saw a substantial fall in profitability, with a 25.16% decrease in profit. The company's net worth Soared by an impressive increase of 16.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Maxlive Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹125,907,846.00
₹8,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2025 | Others | ₹1.78 Cr | Open |
| 19 Oct 2024 | Others | ₹4.22 Cr | Open |
| 15 Mar 2024 | Others | ₹1.01 M | Open |
| 14 Jun 2023 | Others | ₹3.00 Cr | Open |
| 06 Oct 2020 | Hdfc Bank Limited | ₹3.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Maxlive Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maxlive Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxlive Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 42.20 M registered on 19 Oct 2024 with Charge ID 100988618 was modified on 06 Nov 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 17.80 M with Charge ID 101177118 was registered on 13 Oct 2025. was documented.
Progress on A charge with Others amounted to Rs. 42.20 M with Charge ID 100988618 was registered on 19 Oct 2024. was documented.
The activity Maxlive Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Maxlive Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.01 M with Charge ID 100900510 was registered on 15 Mar 2024. was completed.
The CIN of Maxlive Pharmaceuticals Private Limited is U24233UP2011PTC048133.
Maxlive Pharmaceuticals Private Limited is headquartered at Shop No. Ii-7/6 Ground Floor, Block-7, Sector-2, Rajendra Nagar, Sahibabad, Uttar Pradesh, 201005.
Maxlive Pharmaceuticals Private Limited was incorporated on 29 December 2011.
The current directors of Maxlive Pharmaceuticals Private Limited are
The primary industry of Maxlive Pharmaceuticals Private Limited is Trade.
Maxlive Pharmaceuticals Private Limited is unlisted.
The authorized capital of Maxlive Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Maxlive Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX